Welcome to our dedicated page for Alset Capital Acquisition news (Ticker: acax), a resource for investors and traders seeking the latest updates and insights on Alset Capital Acquisition stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Alset Capital Acquisition's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Alset Capital Acquisition's position in the market.
Alset Capital Acquisition Corp. (NASDAQ:ACAX) announced a merger agreement with HWH International Inc., a growing lifestyle company. The merger, approved by both companies' boards, aims to complete by Q4 2022, pending regulatory and stockholder approvals. Post-merger, HWH will trade under a new NASDAQ ticker. HWH operates a membership model for products and services related to health, wealth, and happiness. Existing ACAX stockholders will receive shares in HWH at a conversion of 1:10 for rights. The transaction claims an attractive valuation and growth potential.
FAQ
What is the market cap of Alset Capital Acquisition (acax)?
